April 2025
1. AUBREY BJ, Blonquist T, McMasters M, Hobbs G, et al
   A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
   Leuk Res. 2025;153:107693.
   

   >> Share

   
   January 2025
2. CHO H, Kim J, Park Y, Lee BH, et al
   The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma.
   Leuk Res. 2025;149:107641.
   

   >> Share

   
   December 2024
3. SHAHZAD M, Iqbal Q, Amin MK, Irfan S, et al
   Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis.
   Leuk Res. 2024;148:107640.
   

   >> Share

   
   November 2024
4. ROUZBAHANI M, Mousavi SA, Hajianfar G, Ghanaati A, et al
   Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation using machine learning techniques.
   Leuk Res. 2024;148:107619.
   

   >> Share

   
   
5. LUCCHINI G, Cozma E, Jackson A, Gilmour K, et al
   COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.
   Leuk Res. 2024;147:107618.
   

   >> Share

   
   
6. HUANG X, Wu X, Wang S, Ren Y, et al
   Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single center.
   Leuk Res. 2024;147:107617.
   

   >> Share

   
   October 2024
7. WAIS V, Gantner A, Strauss K, Neagoie A, et al
   Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population.
   Leuk Res. 2024;147:107611.
   

   >> Share

   
   August 2024
8. SHIMIZU H, Kato J, Tanoue S, Kimura SI, et al
   Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols.
   Leuk Res. 2024;144:107562.
   

   >> Share

   
   April 2024
9. INDRAN T, Das T, Muirhead J, O'Brien M, et al
   Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34(+) and CD3(+) donor chim
   Leuk Res. 2024;142:107504.
   

   >> Share

   
   
10. ASHOURI K, Ginosyan AA, Chu M, Hom B, et al
    Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
    Leuk Res. 2024;141:107501.
    

    >> Share

    
    March 2024
11. BRUNETTI M, Iasenza IA, Jenner AL, Raynal NJ, et al
    Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
    Leuk Res. 2024;140:107485.
    

    >> Share

    
    
12. KILIC GUNES E, Yigit Kaya S, Yaman F, Yeniay MK, et al
    Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Leuk Res. 2024;140:107484.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share